AZN
AstraZeneca PLCStock · Health Care$161.07−$0.43 (-0.27%)as of market close, Aug 6, 2026
AZN — AstraZeneca PLC stock price, chart and key statistics
Key stats
Price data
- Price
- $161.07
- Change YTD
- -12.40%
- Market cap
- 251.6B
- Enterprise value
- 270.6B
- Shares outstanding
- 1.6B
- 52W low
- $145.80
- 52W high
- $212.71
- From 52W high
- -24.28%
- From 52W low
- +10.47%
- 52W range
- 23%
- Beta
- 0.26
Volume
- Rel volume
- 0.63×
- 30D volume
- 3.5M
- 30D $ vol
- 597.2M
Fundamentals
- Sales (ttm)
- 58.7B
- Sales/share
- $37.60
- EPS (ttm)
- $6.54
- FCF (ttm)
- 14.6B
- FCF/share
- $9.33
- Book value/share
- $31.16
- Net margin
- 17.42%
- ROE
- 21.03%
- ROA
- 8.97%
- Debt / equity
- 0.51×
- Current ratio
- 0.94
Growth (CAGR, ttm) · 10Y
- Sales
- +9.04%
- Net income
- +13.73%
- Shares
- +2.13%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +11.36%
- Sales/share
- +6.77%
- Book value/share
- +7.86%
- Dividend/share
- +1.13%
- Price
- +8.92%
- Total return
- +10.74%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 24.6×
- P/OI (ttm)
- 18.3×
- Fwd P/E
- 13.9×
- P/S (ttm)
- 4.3×
- P/B (mrq)
- 5.2×
- P/FCF (ttm)
- 17.3×
- EV/EBITDA (fy)
- 19.7×
- EV/Sales (ttm)
- 4.6×
- FCF yield (ttm)
- 5.79%
- Dividend yield (fwd)
- 1.94%
- Dividend/share (fwd)
- $3.13
- Buyback yield (realized, 1y)
- 0.06%
- Shareholder yield (realized, 1y)
- 1.99%
- Buyback yield (cash, ttm)
- -0.02%
- Shareholder yield (cash, ttm)
- 1.91%
Vs own 10Y history
- P/E
- 7th
- P/OI
- 12th
- P/S
- 28th
- P/B
- 19th
Bar = where today's multiple sits in AZN's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return
1D
-0.27%
1W
-5.99%
1M
-14.90%
3M
-12.90%
YTD
-12.40%
1Y
+8.13%
5Y
+39.72%
Financial statements
Open full AZN financials →Related Health Care
1MAstraZeneca PLC (AZN) trades at $161.07 with a live price and an interactive chart covering 17+ years of daily price history, plus key valuation metrics. ChartRow also publishes AZN's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full AZN financial statements →